重磅-话题@MedSci

#重磅#

1136篇内容 | 2553人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1549701, encodeId=12431549e0177, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=BMJ：重磅！冠脉重建后DAPT治疗的核心地位被动摇，P2Y12抑制剂单药治疗或收益更大, objectType=article, longId=212913, objectId=5ce1212913f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ce1212913f0, replyNumber=0, likeNumber=55, createdTime=2021-06-20, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ce1212913f0, moduleTitle=BMJ：重磅！冠脉重建后DAPT治疗的核心地位被动摇，P2Y12抑制剂单药治疗或收益更大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ce1212913f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549700, encodeId=27631549e0007, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=Lancet子刊 | RET抑制剂--Pralsetinib治疗甲状腺癌，实现生存重磅突破！, objectType=article, longId=212611, objectId=74632126115d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74632126115d, replyNumber=0, likeNumber=56, createdTime=2021-06-13, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74632126115d, moduleTitle=Lancet子刊 | RET抑制剂--Pralsetinib治疗甲状腺癌，实现生存重磅突破！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74632126115d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549699, encodeId=4394154969917, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=Nature子刊重磅研究：告别腰穿！血液检测神经丝光链辅助诊断神经退行性疾病, objectType=article, longId=212507, objectId=6a2f21250e24, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a2f21250e24, replyNumber=0, likeNumber=0, createdTime=2021-06-11, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a2f21250e24, moduleTitle=Nature子刊重磅研究：告别腰穿！血液检测神经丝光链辅助诊断神经退行性疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a2f21250e24)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549698, encodeId=86dc1549698d7, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=ASCO 2021期间马骏团队再发鼻咽癌重磅研究, objectType=article, longId=212463, objectId=a8bf212463ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8bf212463ef, replyNumber=0, likeNumber=100, createdTime=2021-06-10, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8bf212463ef, moduleTitle=ASCO 2021期间马骏团队再发鼻咽癌重磅研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8bf212463ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549697, encodeId=380f154969e9c, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=ASCO 2021：荣昌生物ADC新药维迪西妥单抗再次亮相大会，展示重磅临床数据！, objectType=article, longId=212341, objectId=7b272123415c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b272123415c, replyNumber=0, likeNumber=75, createdTime=2021-06-07, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b272123415c, moduleTitle=ASCO 2021：荣昌生物ADC新药维迪西妥单抗再次亮相大会，展示重磅临床数据！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b272123415c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549696, encodeId=0fb615496969e, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=ASCO 2021: 摘要概览与展望 17 | 肝细胞癌重磅研究进展（第二期）, objectType=article, longId=212157, objectId=195421215ead, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=195421215ead, replyNumber=0, likeNumber=42, createdTime=2021-06-03, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=195421215ead, moduleTitle=ASCO 2021: 摘要概览与展望 17 | 肝细胞癌重磅研究进展（第二期）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=195421215ead)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549695, encodeId=3d6c154969554, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=重磅！三孩生育政策来了！, objectType=article, longId=212117, objectId=a08221211e75, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a08221211e75, replyNumber=0, likeNumber=15, createdTime=2021-06-02, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a08221211e75, moduleTitle=重磅！三孩生育政策来了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a08221211e75)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549694, encodeId=6668154969475, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=ASCO 2021: 摘要概览与展望 6 | 肝细胞癌重磅研究一览, objectType=article, longId=211894, objectId=b2b42118942f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2b42118942f, replyNumber=0, likeNumber=0, createdTime=2021-05-28, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2b42118942f, moduleTitle=ASCO 2021: 摘要概览与展望 6 | 肝细胞癌重磅研究一览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2b42118942f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549692, encodeId=e0fd1549692b0, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=医保局重磅文件，医保谈判药物可“双通道”购买, objectType=article, longId=211076, objectId=2a022110e6cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a022110e6cd, replyNumber=0, likeNumber=66, createdTime=2021-05-12, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a022110e6cd, moduleTitle=医保局重磅文件，医保谈判药物可“双通道”购买, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a022110e6cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549690, encodeId=03c51549690b1, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle= 重磅！国内最佳治疗铂敏感及铂耐药复发性卵巢癌的PARP抑制剂帕米帕利获批, objectType=article, longId=210714, objectId=1c60210e1466, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c60210e1466, replyNumber=0, likeNumber=98, createdTime=2021-05-02, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c60210e1466, moduleTitle= 重磅！国内最佳治疗铂敏感及铂耐药复发性卵巢癌的PARP抑制剂帕米帕利获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c60210e1466)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549691, encodeId=ac9b154969153, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=罗氏重磅新药舒友立乐®在华斩获新适应症，助力更多A型血友病患者迈向“零出血”自由人生, objectType=article, longId=210711, objectId=8b33210e118c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b33210e118c, replyNumber=0, likeNumber=99, createdTime=2021-05-02, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b33210e118c, moduleTitle=罗氏重磅新药舒友立乐®在华斩获新适应症，助力更多A型血友病患者迈向“零出血”自由人生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b33210e118c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549689, encodeId=c6e6154968914, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=EHRA 2021｜《2021 EHRA 房颤患者NOACs应用实践指南》重磅发布！, objectType=article, longId=210559, objectId=4e612105596b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e612105596b, replyNumber=0, likeNumber=63, createdTime=2021-04-29, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e612105596b, moduleTitle=EHRA 2021｜《2021 EHRA 房颤患者NOACs应用实践指南》重磅发布！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e612105596b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549688, encodeId=7d81154968870, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=Gut重磅！全球近100万人研究推翻痔疮定义，史上首次确定痔疮找到原因, objectType=article, longId=210474, objectId=d68a2104e4c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d68a2104e4c2, replyNumber=0, likeNumber=61, createdTime=2021-04-27, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d68a2104e4c2, moduleTitle=Gut重磅！全球近100万人研究推翻痔疮定义，史上首次确定痔疮找到原因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d68a2104e4c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549687, encodeId=1465154968e52, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=重磅：2020中国高被引学者榜单正式发布！, objectType=article, longId=210459, objectId=17b8210459a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17b8210459a4, replyNumber=0, likeNumber=115, createdTime=2021-04-27, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17b8210459a4, moduleTitle=重磅：2020中国高被引学者榜单正式发布！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17b8210459a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549693, encodeId=c1fa154969305, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=12个优秀项目+重磅点评嘉宾，细胞与基因治疗项目路演参会报名, objectType=article, longId=210337, objectId=922f21033eb9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=922f21033eb9, replyNumber=0, likeNumber=74, createdTime=2021-04-24, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=922f21033eb9, moduleTitle=12个优秀项目+重磅点评嘉宾，细胞与基因治疗项目路演参会报名, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=922f21033eb9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549686, encodeId=903c1549686bd, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=CDS今日重磅发布指南——《中国2型糖尿病防治指南（2020年版）》, objectType=article, longId=210208, objectId=a93d21020878, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a93d21020878, replyNumber=0, likeNumber=59, createdTime=2021-04-21, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a93d21020878, moduleTitle=CDS今日重磅发布指南——《中国2型糖尿病防治指南（2020年版）》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a93d21020878)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549684, encodeId=7f31154968483, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=中美发表气候声明，柳叶刀、BMJ、Science连发重磅：人类健康因气候变化倒退50年, objectType=article, longId=210180, objectId=4ece210180df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ece210180df, replyNumber=0, likeNumber=116, createdTime=2021-04-21, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ece210180df, moduleTitle=中美发表气候声明，柳叶刀、BMJ、Science连发重磅：人类健康因气候变化倒退50年, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ece210180df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549682, encodeId=b09e1549682b0, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=2021年潜在的重磅炸弹药物，聚焦阿尔茨海默症、前列腺癌……, objectType=article, longId=209544, objectId=a52c20954469, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a52c20954469, replyNumber=0, likeNumber=75, createdTime=2021-04-05, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a52c20954469, moduleTitle=2021年潜在的重磅炸弹药物，聚焦阿尔茨海默症、前列腺癌……, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a52c20954469)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549681, encodeId=efa61549681cf, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=曝某跨国药企重磅糖尿病业务模式调整, objectType=article, longId=209495, objectId=2a75209495d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a75209495d3, replyNumber=0, likeNumber=80, createdTime=2021-04-05, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a75209495d3, moduleTitle=曝某跨国药企重磅糖尿病业务模式调整, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a75209495d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1549680, encodeId=c61e1549680f9, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, objectTitle=重磅发布！全国公立医院绩效考核TOP20排名出炉, objectType=article, longId=209312, objectId=2d2b20931268, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d2b20931268, replyNumber=0, likeNumber=71, createdTime=2021-04-03, rootId=0, userName=xxxx1054, userId=3acc14121561, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d2b20931268, moduleTitle=重磅发布！全国公立医院绩效考核TOP20排名出炉, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d2b20931268)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

重磅

2020-05-29

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

BMJ：重磅！冠脉重建后DAPT治疗的核心地位被动摇，P2Y12抑制剂单药治疗或收益更大

2021-06-20

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

Lancet子刊 | RET抑制剂--Pralsetinib治疗甲状腺癌，实现生存重磅突破！

2021-06-13

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

Nature子刊重磅研究：告别腰穿！血液检测神经丝光链辅助诊断神经退行性疾病

2021-06-11

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

ASCO 2021期间马骏团队再发鼻咽癌重磅研究

2021-06-10

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

ASCO 2021：荣昌生物ADC新药维迪西妥单抗再次亮相大会，展示重磅临床数据！

2021-06-07

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

ASCO 2021: 摘要概览与展望 17 | 肝细胞癌重磅研究进展（第二期）

2021-06-03

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

重磅！三孩生育政策来了！

2021-06-02

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

ASCO 2021: 摘要概览与展望 6 | 肝细胞癌重磅研究一览

2021-05-28

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

医保局重磅文件，医保谈判药物可“双通道”购买

2021-05-12

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

重磅！国内最佳治疗铂敏感及铂耐药复发性卵巢癌的PARP抑制剂帕米帕利获批

2021-05-02

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

罗氏重磅新药舒友立乐®在华斩获新适应症，助力更多A型血友病患者迈向“零出血”自由人生

2021-05-02

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

EHRA 2021｜《2021 EHRA 房颤患者NOACs应用实践指南》重磅发布！

2021-04-29

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

Gut重磅！全球近100万人研究推翻痔疮定义，史上首次确定痔疮找到原因

2021-04-27

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

重磅：2020中国高被引学者榜单正式发布！

2021-04-27

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

12个优秀项目+重磅点评嘉宾，细胞与基因治疗项目路演参会报名

2021-04-24

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

CDS今日重磅发布指南——《中国2型糖尿病防治指南（2020年版）》

2021-04-21

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

中美发表气候声明，柳叶刀、BMJ、Science连发重磅：人类健康因气候变化倒退50年

2021-04-21

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

2021年潜在的重磅炸弹药物，聚焦阿尔茨海默症、前列腺癌……

2021-04-05

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

曝某跨国药企重磅糖尿病业务模式调整

2021-04-05

xxxx1054 (审核中...)

前往app查看评论内容

#重磅#

重磅发布！全国公立医院绩效考核TOP20排名出炉

2021-04-03

科室
- - 订阅+
  - 更多科室
工具
服务